Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
INDUSTRY
×
Nervous System Diseases
×
Clear all
Filters
3
NCT07098806
2025-08-01
CA2024-LM-001
Plus Therapeutics
Phase 1
Recruiting
24 enrolled
NCT02197169
2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1
Completed
37 enrolled